Pfizer and BioNTech Challenge Moderna Patents for Corona Vaccine – Health

2023-08-29 07:18:39

Mainz/New York/Cambridge – The US pharmaceutical company Pfizer and its German partner BioNTech are applying for the cancellation of Moderna’s patents on the corona vaccination technology in the USA. The two patents are “unimaginably general” and cover a basic idea that has been “known for a long time,” the vaccine manufacturers said on Monday before the US Patent Office’s Board of Appeal. The drugmakers also filed opposition to a third, related Moderna patent.

1693293677
#Pfizer #BioNTech #Challenge #Moderna #Patents #Corona #Vaccine #Health

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.